Log in
Enquire now
‌

US Patent 9504758 Modified antibody, antibody-conjugate and process for the preparation thereof

Patent 9504758 was granted and assigned to SynAffix B.V. on November, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
SynAffix B.V.
0
Current Assignee
‌
SynAffix B.V.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
95047580
Patent Inventor Names
Maria Antonia Wijdeven0
Remon Van Geel0
Floris Louis Van Delft0
Date of Patent
November 29, 2016
0
Patent Application Number
148075030
Date Filed
July 23, 2015
0
Patent Citations Received
‌
US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies
0
‌
US Patent 11986537 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
0
‌
US Patent 12018087 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
0
0
‌
US Patent 12102687 Muscle targeting complexes and uses thereof for treating myotonic dystrophy
0
‌
US Patent 11672872 Anti-transferrin receptor antibody and uses thereof
0
...
Patent Primary Examiner
‌
Misook Yu
0
Patent abstract

An antibody comprising a GlcNAc—S(A)x substituent is disclosed, wherein S(A)x is a sugar derivative comprising x functional groups A wherein A is independently selected from the group consisting of an azido group, a keto group and an alkynyl group and x is 1, 2, 3 or 4, wherein said GlcNAc—S(A)x substituent is bonded to the antibody via C1 of the N-acetylglucosamine of said GlcNAc—S(A)x substituent, and wherein said N-acetylglucosamine is optionally fucosylated. Also disclosed is an antibody-conjugate, in particular to an antibody-conjugate according to the Formula (20) or (20b), wherein AB is an antibody, S is a sugar or a sugar derivative, D is a molecule of interest, and wherein said N-acetylglucosamine is optionally fucosylated (b is 0 or 1).

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9504758 Modified antibody, antibody-conjugate and process for the preparation thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us